KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Abbott Laboratories (ABT) Leases (2019 - 2025)

Abbott Laboratories (ABT) has disclosed Leases for 7 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • Quarterly Leases rose 4.74% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, up 4.74% year-over-year, with the annual reading at $1.1 billion for FY2025, 4.74% up from the prior year.
  • Leases hit $1.1 billion in Q4 2025 for Abbott Laboratories, up from $1.1 billion in the prior quarter.
  • In the past five years, Leases ranged from a high of $1.2 billion in Q4 2021 to a low of $1.1 billion in Q4 2024.
  • Historically, Leases has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2023.
  • Biggest five-year swings in Leases: decreased 4.19% in 2024 and later rose 4.74% in 2025.
  • Year by year, Leases stood at $1.2 billion in 2021, then dropped by 3.21% to $1.1 billion in 2022, then rose by 0.54% to $1.1 billion in 2023, then decreased by 4.19% to $1.1 billion in 2024, then grew by 4.74% to $1.1 billion in 2025.
  • Business Quant data shows Leases for ABT at $1.1 billion in Q4 2025, $1.1 billion in Q4 2024, and $1.1 billion in Q4 2023.